The Peierls Foundation

Total investments

9

Average round size

16M

Portfolio companies

6

Rounds per year

0.26

Follow on index

0.33

Exits

3

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareCommunitiesGeneticsMedical DeviceMedicalLife ScienceSocial MediaTherapeuticsBiopharma

Summary

The Peierls Foundation appeared to be the Corporate Investor, which was created in 1988. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the New York.

The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year. This The Peierls Foundation works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the The Peierls Foundation, startups are often financed by Boulder Ventures, Atlas Venture, Remeditex Ventures. The meaningful sponsors for the fund in investment in the same round are Boulder Ventures, PBM Capital Group, Longwood Founders Fund. In the next rounds fund is usually obtained by Boulder Ventures, Remeditex Ventures, Fuse Capital.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight ArcherDX, BiOptix Diagnostics, BaroFold. Among the most popular fund investment industries, there are Genetics, Communities.

Show more

Investments analytics

Analytics

Total investments
9
Lead investments
0
Exits
3
Rounds per year
0.26
Follow on index
0.33
Investments by industry
  • Biotechnology (6)
  • Biopharma (4)
  • Therapeutics (4)
  • Genetics (4)
  • Medical (3)
  • Show 5 more
Investments by region
  • United States (9)
Peak activity year
2007
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
233M
Group Appearance index
1.00
Avg. company exit year
7
Avg. multiplicator
9.33

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ArcherDX 15 May 2019 Biotechnology, Genetics, Life Science, Biopharma Early Stage Venture 60M United States, Boulder, Colorado

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.